Avalon Pharmaceuticals Income Statement
View: Annual
| Dec 08 | Dec 07 | Dec 06 | |
|---|---|---|---|
| Revenue | 0.3 | 0.8 | 2.7 |
| Cost of Goods Sold | 0.0 | -- | -- |
| Gross Profit | -- | -- | -- |
| Gross Profit Margin | 0.0% | 0.0% | 0.0% |
| SG&A Expense | 5.3 | 8.2 | 7.7 |
| Depreciation & Amortization | 1.6 | 2.0 | 2.4 |
| Operating Income | -- | -- | -- |
| Operating Margin | -- | -- | -- |
| Nonoperating Income | 0.1 | 0.1 | 0.6 |
| Nonoperating Expenses | 0.0 | -- | -- |
| Income Before Taxes | -- | -- | -- |
| Income Taxes | -- | -- | -- |
| Net Income After Taxes | 0.0 | 0.0 | 0.0 |
| Continuing Operations | (21.8) | (21.7) | (17.1) |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (21.8) | (21.7) | (17.1) |
| Total Net Income | (21.8) | (21.7) | (17.1) |
| Net Profit Margin | -- | -- | -- |
| Diluted EPS from Total Net Income ($) | (1.24) | (1.42) | (1.74) |
| Dividends per Share | 0.00 | 0.00 | 0.00 |
© 2009 Morningstar, Inc. Financial Data provided by
